Demikhov Municipal Clinical Hospital 68 Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2020
NCT04453371
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Demikhov Municipal Clinical Hospital 68

Active Ingredients

Drugs in Phase 3 Trials (3)

alteplase (Activase) (1 trial)

lithium (lithonate) (1 trial)

ringer's lactate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Lung Injury (Phase 3)

Respiratory Distress Syndrome (Phase 3)

Respiratory Distress Syndrome, Newborn (Phase 3)

Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3